iKang Schedules 2016 Unaudited Third Quarter Earnings Release on March 16, 2017
February 27 2017 - 8:00AM
iKang Healthcare Group, Inc. (“iKang” or the “Company”)
(Nasdaq:KANG), China’s largest private preventive healthcare
services provider, today announced that it will release its
unaudited financial results for the third quarter ended December
31, 2016 on March 16, 2017 after the US market closes.
The earnings press release will be available on
the investor relations page at http://ir.ikang.com.
Conference CalliKang’s
management will host a conference call at 8:00 am US
Eastern Time (8:00 pm Beijing/Hong Kong Time) on March 17,
2017, to discuss its quarterly results and recent business
activities.
To participate in the conference call, please
dial the following number five to ten minutes prior to the
scheduled conference call time:
China: |
4001-200-539 |
Hong Kong: |
800-905-927 |
United States: |
1855-298-3404 |
International: |
+65 6823-2299 |
Passcode: |
9112811 |
The Company will also broadcast a live audio
webcast of the conference call. The webcast will be available at
http://ir.ikang.com.
Following the earnings conference call, an archive of the call
will be available by dialing:
China: |
4001-842-240 |
Hong Kong: |
800-966-697 |
United States: |
1866-846-0868 |
International: |
+61-2-9641-7900 |
Replay Passcode: |
9112811 |
Replay End Date: |
March 31, 2017 |
About iKang Healthcare Group,
Inc.
iKang Healthcare Group, Inc. is the largest
provider in China’s fast growing private preventive healthcare
services market, accounting for approximately 13.6% of market share
in terms of revenue in calendar year 2014.
Through iKang’s integrated service platform and
established nationwide network of medical centers and third-party
service provider facilities, the Company provides comprehensive and
high quality preventive healthcare solutions, including a wide
range of medical examinations services and value-added services
including disease screening and other services. iKang’s customers
are primarily corporate customers who contract with the Company to
provide medical examination services to their employees and
clients, and pay for these services at pre-negotiated prices. iKang
also directly markets its services to individual customers. In the
fiscal year ended March 31, 2016, the Company served a total of 4.6
million customer visits under both corporate and individual
programs.
As of February 27, 2017, iKang’s nationwide
network consisted of 104(1) self-owned medical centers covering 32
of the most affluent cities in China, namely Beijing, Shanghai,
Guangzhou, Shenzhen, Chongqing, Tianjin, Nanjing, Suzhou, Hangzhou,
Chengdu, Fuzhou, Changchun, Jiangyin, Changzhou, Wuhan, Changsha,
Yantai, Yinchuan, Weihai, Weifang, Shenyang, Xi’an, Wuhu, Guiyang,
Ningbo, Foshan, Jinan, Bijie, Qingdao, Wuxi, Kaili as well as Hong
Kong. The Company has also supplemented its self-owned medical
center network by contracting with approximately 400 third-party
service provider facilities in over 150 cities, which include
select independent medical examination centers and hospitals across
all of China’s provinces, creating a nationwide network that allows
iKang to serve its customers in markets where it does not have
self-owned medical centers.
(1) Among the 104 self-owned medical centers,
two medical centers are currently operated primarily by the
minority shareholders of these medical centers or their parent
company.
Forward-looking Statements
This press release contains forward-looking
statements. These statements, including management quotes and
business outlook, are made under the “safe harbor” provisions of
the U.S. Private Securities Litigation Reform Act of 1995. These
forward-looking statements can be identified by terminology such as
”will,” "estimate," "project," "predict," "believe," "expect,"
"anticipate," "intend," "potential," "plan," "goal" and similar
statements. iKang may also make written or oral
forward-looking statements in its periodic reports to the U.S.
Securities and Exchange Commission, in its annual report to
shareholders, in press releases and other written materials and in
oral statements made by its officers, directors or employees to
third parties. Such statements involve certain risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied in the forward-looking statements.
These forward-looking statements include, but are not limited to,
statements about: the Company’s goals and strategies; its future
business development, financial condition and results of
operations; its ability to retain and grow its customer base and
network of medical centers; the growth of, and trends in, the
markets for its services in China; the demand for and market
acceptance of its brand and services; competition in its industry
in China; relevant government policies and regulations relating to
the corporate structure, business and industry; fluctuations in
general economic and business conditions in China. Further
information regarding these and other risks is included in iKang’s
filing with the Securities and Exchange Commission. iKang
undertakes no duty to update any forward-looking statement as a
result of new information, future events or otherwise, except as
required under applicable law.
IR Contact:
iKang Healthcare Group, Inc.
Christy Xie
Director of Investor Relations
Tel: +86 10 5320 8599
Email: ir@ikang.com
Website: www.ikanggroup.com
FleishmanHillard
Ruby Yim
Email: ikang@fleishman.com
IKANG HEALTHCARE GROUP, INC. (NASDAQ:KANG)
Historical Stock Chart
From Mar 2024 to Apr 2024
IKANG HEALTHCARE GROUP, INC. (NASDAQ:KANG)
Historical Stock Chart
From Apr 2023 to Apr 2024